<DOC>
	<DOCNO>NCT00531050</DOCNO>
	<brief_summary>This study investigate effect exercise high-dose salbutamol maximum heart rate patient chronic obstructive pulmonary disease ( COPD ) receive therapeutic dos indacaterol , salmeterol placebo .</brief_summary>
	<brief_title>Safety Exercise High-dose Salbutamol Patients With Chronic Obstructive Pulmonary Disease ( COPD ) Receiving Therapeutic Doses Indacaterol ( QAB 149 ) Salmeterol</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Patients 40 75 year age diagnose chronic obstructive pulmonary disease ( COPD ) . Female patient must surgically sterilize , postmenopausal use doublebarrier method contraception . Body mass index ( BMI ) must within range 18 32 . Participation clinical investigation experimental drug therapy within four week prior dose longer required local regulation . Donation loss 400 mL blood within two month prior dose . Significant illness ( respiratory ) within two week prior dose . A past medical history , family history ( grandparent , parent sibling ) prolong QTinterval syndrome prolong QTinterval screen . Any clinically significant medical abnormality ( exclude COPD ) limit ability perform standardize exercise protocol cycle ergometer exclude patient . For example , arthritis . History clinically significant drug allergy history atopic allergy ( asthma , urticaria , eczematous dermatitis ) . A known hypersensitivity study drug drug similar study drug . History immunocompromise , include positive HIV , Hepatitis B C test result . History drug alcohol abuse within 12 month prior dose Any condition opinion investigator may compromise patient safety , interfere evaluation , preclude completion trial . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>COPD</keyword>
	<keyword>cycle ergometry</keyword>
	<keyword>exercise test</keyword>
	<keyword>spirometry</keyword>
	<keyword>cardiovascular</keyword>
	<keyword>salbutamol</keyword>
	<keyword>indacaterol</keyword>
	<keyword>chronic obstructive pulmonary disease</keyword>
</DOC>